These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3120322)

  • 1. [Clinical significance of antibodies to proliferating cell nuclear antigen (PCNA)].
    Ohata N
    Ryumachi; 1987 Apr; 27(2):79-87. PubMed ID: 3120322
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Systemic lupus erythematosus and antinuclear factors, with special reference to its diagnostic significance and relationship to the etiology of lupus nephritis].
    Nagasawa T
    Saishin Igaku; 1969 Oct; 24(10):2082-96. PubMed ID: 5307586
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-PCNA antibody].
    Yamanaka K; Takasaki Y
    Rinsho Byori; 1993 Aug; 41(8):888-96. PubMed ID: 8103808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic tests: Anti-proliferating cell nuclear antigen (PCNA) antibody].
    Takasaki Y
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():529-31. PubMed ID: 16111322
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical significance of determining anti-extractable nuclear antigen in subjects with immunofluorecent negative anti-nuclear antibodies].
    Sakai H; Katayama Y; Haranou Y
    Rinsho Byori; 1989 Feb; 37(2):159-63. PubMed ID: 2499708
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical significance of screening for antibody to ribonucleoprotein.
    Small P; Barrett D; Champlin E
    Ann Allergy; 1982 Sep; 49(3):152-5. PubMed ID: 6981365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of rheumatic diseases: tests and traps.
    Schmidt MC
    Hosp Pract (Off Ed); 1984 Sep; 19(9):82E-82G, 82K, 82O passim. PubMed ID: 6432827
    [No Abstract]   [Full Text] [Related]  

  • 9. The antinuclear antibody test. When is a positive result clinically relevant?
    Thomas C; Robinson JA
    Postgrad Med; 1993 Aug; 94(2):55-8, 63, 66. PubMed ID: 8341626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-U1RNP antibodies and lupus nephritis].
    Ilić T; Curić S; Vodopivec S; Mitić I; Durdević-Mirković T; Sakac V; Lenert P
    Med Pregl; 2000; 53(11-12):589-94. PubMed ID: 11320745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assays for Sm and RNP antibodies: pitfalls and technical considerations.
    Molden DP; Suzuki H; Nakamura RM
    Diagn Immunol; 1985; 3(1):24-8. PubMed ID: 3922661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic significance of antinuclear antibodies in pleural effusion.
    Leechawengwong M; Berger HW; Sukumaran M
    Mt Sinai J Med; 1979; 46(2):137-9. PubMed ID: 312438
    [No Abstract]   [Full Text] [Related]  

  • 13. [The Ha(La) antibody as a serologic marker of systemic lupus erythematosus].
    Lakomek HJ; Wagener S; Schwochau M; Krüskemper HL
    Z Rheumatol; 1988; 47(2):86-92. PubMed ID: 3260430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Theoretical objective evaluation of the value of a diagnostic criterion. Application to antinuclear antibodies for the diagnosis of systemic lupus erythematosus].
    Vinceneux P; Yeni P; Boboc B; Carbon C
    Rev Rhum Mal Osteoartic; 1984 Oct; 51(9):493-6. PubMed ID: 6334353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of anti-DNA antibody].
    Tojo T; Kaburaki J
    Nihon Rinsho; 1990 Feb; 48 Suppl():474-7. PubMed ID: 2192141
    [No Abstract]   [Full Text] [Related]  

  • 16. Antinuclear antibodies directed against proliferating cell nuclear antigen are not specifically associated with systemic lupus erythematosus.
    Vermeersch P; De Beeck KO; Lauwerys BR; Van den Bergh K; Develter M; Mariën G; Houssiau FA; Bossuyt X
    Ann Rheum Dis; 2009 Nov; 68(11):1791-3. PubMed ID: 19822716
    [No Abstract]   [Full Text] [Related]  

  • 17. Appropriate laboratory testing in rheumatic diseases.
    Metzger AL; Morris RI
    Lippincotts Prim Care Pract; 1998; 2(1):52-65. PubMed ID: 9451199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis of the correlation between the LE-phenomenon and antinuclear factor in systemic lupus erythematosus].
    Zhuravlev GI; Rodshteĭn OA; Shishkin VI
    Ter Arkh; 1971 Jul; 43(7):110-5. PubMed ID: 4113161
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical utility of common serum rheumatologic tests.
    Lane SK; Gravel JW
    Am Fam Physician; 2002 Mar; 65(6):1073-80. PubMed ID: 11925083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation between organic changes, antibodies against native DNA and antinuclear antibody titer in patients with systemic lupus erythematosus].
    Marczak M; Kardaszewicz E
    Pol Tyg Lek; 1985 Jun; 40(23):654-6. PubMed ID: 3876550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.